CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #adaptivetrials --Cytel Inc., a global provider of adaptive trial design software, statistical consultancy, and clinical research services, today announced the release of East® version 6.4. East®, the life science industry’s leading clinical trial design platform, will deliver expanded functionality to support the application of groundbreaking methods including multi-arm multi-stage designs, and dual agent dose escalation designs for combination therapies. With ever-increasing
For more information, please visit
http://www.businesswire.com/news/home/20[...]daptive-designs-East%C2%AE-6.4